Chao Kong

Director of China External Innovation at HiFiBiO

Previously, Chao Kong worked for SanyouBio Pharmaceuticals for over five years, providing multiple services from antibody discovery to IND enabling studies. He is experienced in pre-clinical target validation, antibody discovery biology, and project management. In addition, he holds a strong background in target biology and cancer immunotherapy.

Chao Kong received a master’s degree from Shanghai University & Shanghai Pasteur Institute of the Chinese Academy of Sciences in China, majoring in Microbiology and Molecular Immunology.


Org chart